Sign In
Buy LPTX
$0.690
+0 (+0%)
At Close: Jun 23, 2026
Financial Contrast: Leap Therapeutics (NASDAQ:LPTX) & Tiziana Life Sciences (NASDAQ:TLSA)
05:52am, Wednesday, 22'nd Apr 2020
Leap Therapeutics (NASDAQ:LPTX) and Tiziana Life Sciences (NASDAQ:TLSA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the streng
One Thing To Remember About The Leap Therapeutics, Inc. (NASDAQ:LPTX) Share Price
04:25pm, Tuesday, 07'th Apr 2020
If you're interested in Leap Therapeutics, Inc. (NASDAQ:LPTX), then you might want to consider its beta (a measure of...
Leap Therapeutics Announces Executive Leadership Changes
11:00am, Wednesday, 18'th Mar 2020
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced changes to the Company's Executive Leadership Team. All
Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
11:00am, Monday, 16'th Mar 2020
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended
Analyzing Homology Medicines (NASDAQ:FIXX) & Leap Therapeutics (NASDAQ:LPTX)
07:14am, Wednesday, 04'th Mar 2020
Homology Medicines (NASDAQ:FIXX) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the streng
Head to Head Review: Leap Therapeutics (NASDAQ:LPTX) vs. Esperion Therapeutics (NASDAQ:ESPR)
08:18am, Tuesday, 03'rd Mar 2020
Leap Therapeutics (NASDAQ:LPTX) and Esperion Therapeutics (NASDAQ:ESPR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the stre
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
S, TMUS among premarket gainers
02:18pm, Tuesday, 11'th Feb 2020
Sprint (NYSE:S) +74% after judge approves T-Mobile merger.Rexahn Pharmaceuticals (NASDAQ:REXN) +25%.ZK International Group (NASDAQ:ZKIN) +21% on supplying stainless steel pipe and fitting products f
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
12:00pm, Thursday, 23'rd Jan 2020
Leap Therapeutics, Inc. (Nasdaq: LPTX) today presented updated clinical data from its recently completed Phase 1/2 clinical trial of DKN-01 in patients with advanced or recurrent esophagogastric cance
Leap Therapeutics Announces Closing of Previously Announced Equity Financing
09:05pm, Tuesday, 07'th Jan 2020
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of its previously announced equity financin
Leap Therapeutics Surges on License Agreement With BieGene
01:25pm, Monday, 06'th Jan 2020
Leap Therapeutics (LPTX) signs agreement with China-based BieGene granting the latter rights to develop its pipeline candidate, DKN-01. It also signs equity financing deals worth $27 million.
Cash-strapped biotech signs deal with Chinese drugmaker BeiGene
07:11pm, Friday, 03'rd Jan 2020
A small Cambridge biotech is getting a much-needed infusion of cash, signing what its CEO called a “transformative” collaboration deal with Chinese drugmaker BeiGene Ltd.
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted immuno-oncology therapeutics, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical co
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
03:09pm, Friday, 15'th Nov 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89
Leap Therapeutics Reports Third Quarter 2019 Financial Results
12:00pm, Thursday, 14'th Nov 2019
- DKN-01 data continues to show robust activity, including a monotherapy complete response, in cancer patients with high DKK-1 expression and Wnt signaling alterations - De-prioritizing further develo
